Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Empagliflozin Improves Cardiomyocyte Function in Phospholamban‐R14del Cardiomyopathy by Regulating Calcium/Calmodulin‐Stimulated Protein Kinase II Activity and Apoptosis

Journal of the American Heart Association(2025)10.1161/jaha.125.042432Source: DataRank Database

Empagliflozin Improves Cardiomyocyte Function in Phospholamban‐R14del Cardiomyopathy by Regulating Calcium/Calmodulin‐Stimulated Protein Kinase II Activity and Apoptosis is a research paper published in Journal of the American Heart Association (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Alexander Li ORCID,Barbara E. Vecci ORCID,David Staudt ORCID,Ricardo Serrano ORCID,Xiaozhi Gao ORCID

Live enrichment

PubMed:41147384 PMC:PMC12684771 OpenAlex:https://openalex.org/W4415612203

NIH HHS

Grant: S10 OD030264

NCI NIH HHS

Grant: K99 CA279895

NHLBI NIH HHS

Grant: R01 HL170080

NHLBI NIH HHS

Grant: R01 HL130840

NHLBI NIH HHS

Grant: R33 HL167258

FWCI

0.00

Citation Percentile

0.4%

goldLicense: cc-by-nc-nd

journalhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.125.042432?download=true

publisherhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.125.042432?download=true

publisherhttps://www.ahajournals.org/doi/full/10.1161/JAHA.125.042432

journalhttps://doi.org/10.1161/jaha.125.042432

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41147384

Fields of Study

Cardiovascular Function and Risk FactorsDiabetes Treatment and ManagementCardiac Fibrosis and Remodeling

Keywords

EmpagliflozinApoptosisCardiomyopathyFunction (biology)Diabetic cardiomyopathyKinaseProtein kinase AHeart failureCardiac function curveCardiomyocytesCaMKIISglt2 InhibitorDrug RepurposingIpscPln Cardiomyopathy